Validation of an LC-MS/MS Method for the Simultaneous Intracellular Quantification of the CDK4/6 Inhibitor Abemaciclib and the EZH2 Inhibitors GSK126 and Tazemetostat by Stefan Senekowitsch, Thomas Freitag, Daniel Dubinski, Thomas M. Freiman, Claudia Maletzki, Burkhard Hinz

Get full text

Inhibition of platin-induced BCL2 increase overcomes chemoresistance in squamous cell carcinoma of the head and neck through resensitization to cell death by Anne-Sophie Becker, Friederike Klauk, Thomas Freitag, Daniel Fabian Strüder, Björn Schneider, Annette Zimpfer, Claudia Maletzki

Get full text

Short-term immune-checkpoint inhibition partially rescues perturbed bone marrow hematopoiesis in mismatch-repair deficient tumors by Paula Krone, Annabell Wolff, Julia Teichmann, Johanna Maennicke, Julia Henne, Leonie Engster, Inken Salewski, Wendy Bergmann, Christian Junghanss, Claudia Maletzki

Get full text

CDK inhibitors promote neuroblastoma cell differentiation and increase sensitivity to retinoic acid—a promising combination strategy for therapeutic intervention by Fatemeh Shokraie, Larissa Lechermeier, Pia Bordihn, Philipp Kaps, Steffen Möller, Anna Sophie Schulz, Björn Schneider, Dirk Koczan, Samira Khanipour Roshan, Holger N. Lode, Carl-Friedrich Classen, Olga Hahn, Sascha Troschke-Meurer, Claudia Maletzki

Get full text

CDK7 inhibition promotes glioblastoma cell death through convergent transcriptional and metabolic stress pathways by Thomas Freitag, Jana Vanessa Scheffler, Philipp Kaps, Anne Hieltscher, Björn Schneider, Daniel Dubinski, Florian Gessler, Thomas M. Freiman, Felix Wittig, Sascha Troschke‐Meurer, Wendy Bergmann‐Ewert, Susanne Staehlke, Lars Boeckmann, Philipp‐Kjell Ficht, Christian Polley, Christian Junghanss, Burkhard Hinz, Claudia Maletzki

Get full text